These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21084491)

  • 21. Broadly Neutralizing Hemagglutinin Stalk-Specific Antibodies Induce Potent Phagocytosis of Immune Complexes by Neutrophils in an Fc-Dependent Manner.
    Mullarkey CE; Bailey MJ; Golubeva DA; Tan GS; Nachbagauer R; He W; Novakowski KE; Bowdish DM; Miller MS; Palese P
    mBio; 2016 Oct; 7(5):. PubMed ID: 27703076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: implications for HIV primary infection.
    Zaitseva M; Blauvelt A; Lee S; Lapham CK; Klaus-Kovtun V; Mostowski H; Manischewitz J; Golding H
    Nat Med; 1997 Dec; 3(12):1369-75. PubMed ID: 9396607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low levels of productive HIV infection in Langerhans cell-like dendritic cells differentiated in the presence of TGF-beta1 and increased viral replication with CD40 ligand-induced maturation.
    Kawamura T; Qualbani M; Thomas EK; Orenstein JM; Blauvelt A
    Eur J Immunol; 2001 Feb; 31(2):360-8. PubMed ID: 11180099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. When integrated in a subepithelial mucosal layer equivalent, dendritic cells keep their immature stage and their ability to replicate type R5 HIV type 1 strains in the absence of T cell subsets.
    Dumont S; Valladeau J; Bechetoille N; Gofflo S; Maréchal S; Amara A; Schmitt D; Dezutter-Dambuyant C
    AIDS Res Hum Retroviruses; 2004 Apr; 20(4):383-97. PubMed ID: 15157357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Productive infection of dendritic cells by HIV-1 and their ability to capture virus are mediated through separate pathways.
    Blauvelt A; Asada H; Saville MW; Klaus-Kovtun V; Altman DJ; Yarchoan R; Katz SI
    J Clin Invest; 1997 Oct; 100(8):2043-53. PubMed ID: 9329969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficient inhibition of HIV-1 replication in human immature monocyte-derived dendritic cells by purified anti-HIV-1 IgG without induction of maturation.
    Holl V; Peressin M; Schmidt S; Decoville T; Zolla-Pazner S; Aubertin AM; Moog C
    Blood; 2006 Jun; 107(11):4466-74. PubMed ID: 16469871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Report of the Cent Gardes HIV Vaccine Conference: The B-cell response to HIV. Part 2: Non-neutralizing antibodies: Fondation Mérieux Conference Center, Veyrier du Lac, France 5-7 November 2012.
    Girard MP; Picot V; Longuet C; Nabel GJ
    Vaccine; 2013 Jun; 31(29):2984-7. PubMed ID: 23602538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Importance of Fc-mediated functions of anti-HIV-1 broadly neutralizing antibodies.
    Parsons MS; Chung AW; Kent SJ
    Retrovirology; 2018 Aug; 15(1):58. PubMed ID: 30134945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blockage of CD59 Function Restores Activities of Neutralizing and Nonneutralizing Antibodies in Triggering Antibody-Dependent Complement-Mediated Lysis of HIV-1 Virions and Provirus-Activated Latently Infected Cells.
    Yang K; Lan J; Shepherd N; Hu N; Xing Y; Byrd D; Amet T; Jewell C; Gupta S; Kounga C; Gao J; Yu Q
    J Virol; 2015 Sep; 89(18):9393-406. PubMed ID: 26136568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential Role of Nonneutralizing IgA Antibodies in Cross-Protective Immunity against Influenza A Viruses of Multiple Hemagglutinin Subtypes.
    Okuya K; Yoshida R; Manzoor R; Saito S; Suzuki T; Sasaki M; Saito T; Kida Y; Mori-Kajihara A; Kondoh T; Sato M; Kajihara M; Miyamoto H; Ichii O; Higashi H; Takada A
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32269119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acutely infected Langerhans cells are more efficient than T cells in disseminating HIV type 1 to activated T cells following a short cell-cell contact.
    Ayehunie S; Groves RW; Bruzzese AM; Ruprecht RM; Kupper TS; Langhoff E
    AIDS Res Hum Retroviruses; 1995 Aug; 11(8):877-84. PubMed ID: 7492434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitory Effect of Individual or Combinations of Broadly Neutralizing Antibodies and Antiviral Reagents against Cell-Free and Cell-to-Cell HIV-1 Transmission.
    Gombos RB; Kolodkin-Gal D; Eslamizar L; Owuor JO; Mazzola E; Gonzalez AM; Korioth-Schmitz B; Gelman RS; Montefiori DC; Haynes BF; Schmitz JE
    J Virol; 2015 Aug; 89(15):7813-28. PubMed ID: 25995259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro inhibition of HIV-1 replication in autologous CD4
    Tu T; Zhan J; Mou D; Li W; Su B; Zhang T; Li T; Li N; Wu H; Jin C; Chen H
    Virol Sin; 2017 Dec; 32(6):485-494. PubMed ID: 28918477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcitonin Gene-Related Peptide Induces HIV-1 Proteasomal Degradation in Mucosal Langerhans Cells.
    Bomsel M; Ganor Y
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28904199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of two temporal phases of HIV-1 transfer from primary Langerhans cells to T cells: the role of langerin.
    Nasr N; Lai J; Botting RA; Mercier SK; Harman AN; Kim M; Turville S; Center RJ; Domagala T; Gorry PR; Olbourne N; Cunningham AL
    J Immunol; 2014 Sep; 193(5):2554-64. PubMed ID: 25070850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infection of specific dendritic cells by CCR5-tropic human immunodeficiency virus type 1 promotes cell-mediated transmission of virus resistant to broadly neutralizing antibodies.
    Ganesh L; Leung K; Loré K; Levin R; Panet A; Schwartz O; Koup RA; Nabel GJ
    J Virol; 2004 Nov; 78(21):11980-7. PubMed ID: 15479838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Herpes simplex virus type 2 enhances HIV-1 susceptibility by affecting Langerhans cell function.
    de Jong MA; de Witte L; Taylor ME; Geijtenbeek TB
    J Immunol; 2010 Aug; 185(3):1633-41. PubMed ID: 20592277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bispecific Antibodies Targeting Different Epitopes on the HIV-1 Envelope Exhibit Broad and Potent Neutralization.
    Asokan M; Rudicell RS; Louder M; McKee K; O'Dell S; Stewart-Jones G; Wang K; Xu L; Chen X; Choe M; Chuang G; Georgiev IS; Joyce MG; Kirys T; Ko S; Pegu A; Shi W; Todd JP; Yang Z; Bailer RT; Rao S; Kwong PD; Nabel GJ; Mascola JR
    J Virol; 2015 Dec; 89(24):12501-12. PubMed ID: 26446600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses.
    Tay MZ; Liu P; Williams LD; McRaven MD; Sawant S; Gurley TC; Xu TT; Dennison SM; Liao HX; Chenine AL; Alam SM; Moody MA; Hope TJ; Haynes BF; Tomaras GD
    PLoS Pathog; 2016 Aug; 12(8):e1005817. PubMed ID: 27579713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodies.
    Richardson SI; Chung AW; Natarajan H; Mabvakure B; Mkhize NN; Garrett N; Abdool Karim S; Moore PL; Ackerman ME; Alter G; Morris L
    PLoS Pathog; 2018 Apr; 14(4):e1006987. PubMed ID: 29630668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.